| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |